MedStar Health Blog

This phase III interventional, randomized, open-label trial investigates the safety and efficacy of a new second-line treatment for advanced or metastatic breast cancer. Treating advanced or metastat...

Sickle cell anemia or sickle cell disease (SCD) isn’t a single condition. It’s a group of blood disorders that share a common tendency for the blood cells to assume a banana or sickle shape in low-ox...

Everyone’s breasts are different, made up of a unique combination of fat, milk glands, ducts, and fibrous connective tissue. Your individual combination of these types of tissues affects the density ...

MedStar Health Research Institute is collaborating with the DC Department of Health to investigate the reasons for refusal, discontinuation, or delay of breast cancer treatment and to identify potent...

Prostate cancer is the second most common cancer in the U.S., and if it’s detected early there are many effective treatments. Yet many men avoid getting screened, both because these tests have a repu...

MedStar Health Research Institute is now enrolling patients in the prospective, multi-center Pathfinder 2 trial of an early detection test for multiple types of cancer. The sooner cancer is found, th...